 | • レポートコード：MRC2102QY10454 • 出版社/出版日： / 2021年1月 • レポート形態：英文、PDF、134ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：医薬品、医療 |
| Single User | ￥600,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥900,000 (USD6,000) | ▷ お問い合わせ |
| Enterprise License | ￥1,200,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYリサーチ社の本調査レポートでは、世界のPD-1・PD-L1阻害剤市場について種類別（PD-1阻害剤、PD-L1阻害剤）、用途別（固形腫瘍、血液関連腫瘍）、地域別（米国、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。 ・PD-1・PD-L1阻害剤市場の概要 ・世界の主要地域別PD-1・PD-L1阻害剤市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界のPD-1・PD-L1阻害剤市場規模2015-2026：種類別（PD-1阻害剤、PD-L1阻害剤） ・世界のPD-1・PD-L1阻害剤市場規模2015-2026：用途別（固形腫瘍、血液関連腫瘍） ・PD-1・PD-L1阻害剤の米国市場規模2015-2020 ・PD-1・PD-L1阻害剤のヨーロッパ市場規模2015-2020 ・PD-1・PD-L1阻害剤の中国市場規模2015-2020 ・PD-1・PD-L1阻害剤の日本市場規模2015-2020 ・PD-1・PD-L1阻害剤の東南アジア市場規模2015-2020 ・PD-1・PD-L1阻害剤のインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 ・PD-1・PD-L1阻害剤の製造コスト分析 ・販売チャネル、流通業者、顧客 ・PD-1・PD-L1阻害剤の市場動向・機会・課題 ・調査の結論 |
PD-1 inhibitors and PD-L1 inhibitors are a group of checkpoint inhibitors being developed for the treatment of cancer. PD-1 and PD-L1 are both proteins present on the surface of cells. Immune checkpoint inhibitors such as these are emerging as a front-line treatment for several types of cancer.
North America is the largest consumption place, with a consumption market share nearly 60.40% in 2019. Following North America, Europe is the second largest consumption place with the consumption market share of 20.66%.Market competition is intense. Merck, Bristol-Myers Squibb, Roche, AstraZeneca, Ono Pharmaceutical etc. are the leaders of the industry.
Market Analysis and Insights: Global PD-1 and PD-L1 Inhibitors Market
The global PD-1 and PD-L1 Inhibitors market size is projected to reach US$ 99240 million by 2026, from US$ 32840 million in 2020, at a CAGR of 20.2% during 2021-2026.
Global PD-1 and PD-L1 Inhibitors Scope and Market Size
The global PD-1 and PD-L1 Inhibitors market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global PD-1 and PD-L1 Inhibitors market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2015-2026.
Segment by Type, the PD-1 and PD-L1 Inhibitors market is segmented into
PD-1 Inhibitors
PD-L1 Inhibitors
Segment by Application, the PD-1 and PD-L1 Inhibitors market is segmented into
Solid Tumors
Blood-related Tumors
The PD-1 and PD-L1 Inhibitors market is analysed and market size information is provided by regions (countries). Segment by Application, the PD-1 and PD-L1 Inhibitors market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and PD-1 and PD-L1 Inhibitors Market Share Analysis
PD-1 and PD-L1 Inhibitors market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in PD-1 and PD-L1 Inhibitors business, the date to enter into the PD-1 and PD-L1 Inhibitors market, PD-1 and PD-L1 Inhibitors product introduction, recent developments, etc.
The major vendors covered:
Merck
Bristol-Myers Squibb
Roche
AstraZeneca
Ono Pharmaceutical
Regeneron
Innovent
Hengrui Medicine
Junshi Biosciences
Merck KGaA
1 PD-1 and PD-L1 Inhibitors Market Overview
1.1 PD-1 and PD-L1 Inhibitors Product Scope
1.2 PD-1 and PD-L1 Inhibitors Segment by Type
1.2.1 Global PD-1 and PD-L1 Inhibitors Sales by Type (2020-2026)
1.2.2 PD-1 Inhibitors
1.2.3 PD-L1 Inhibitors
1.3 PD-1 and PD-L1 Inhibitors Segment by Application
1.3.1 Global PD-1 and PD-L1 Inhibitors Sales Comparison by Application (2020-2026)
1.3.2 Solid Tumors
1.3.3 Blood-related Tumors
1.4 PD-1 and PD-L1 Inhibitors Market Estimates and Forecasts (2015-2026)
1.4.1 Global PD-1 and PD-L1 Inhibitors Sales Growth Rate (2015-2026)
1.4.2 Global PD-1 and PD-L1 Inhibitors Revenue and Growth Rate (2015-2026)
1.4.3 Global PD-1 and PD-L1 Inhibitors Price Trends (2015-2026)
2 PD-1 and PD-L1 Inhibitors Estimate and Forecast by Region
2.1 Global PD-1 and PD-L1 Inhibitors Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global PD-1 and PD-L1 Inhibitors Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global PD-1 and PD-L1 Inhibitors Sales Market Share by Region (2015-2020)
2.2.2 Global PD-1 and PD-L1 Inhibitors Revenue Market Share by Region (2015-2020)
2.3 Global PD-1 and PD-L1 Inhibitors Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global PD-1 and PD-L1 Inhibitors Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global PD-1 and PD-L1 Inhibitors Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States PD-1 and PD-L1 Inhibitors Estimates and Projections (2015-2026)
2.4.2 Europe PD-1 and PD-L1 Inhibitors Estimates and Projections (2015-2026)
2.4.3 China PD-1 and PD-L1 Inhibitors Estimates and Projections (2015-2026)
2.4.4 Japan PD-1 and PD-L1 Inhibitors Estimates and Projections (2015-2026)
2.4.5 Southeast Asia PD-1 and PD-L1 Inhibitors Estimates and Projections (2015-2026)
2.4.6 India PD-1 and PD-L1 Inhibitors Estimates and Projections (2015-2026)
3 Global PD-1 and PD-L1 Inhibitors Competition Landscape by Players
3.1 Global Top PD-1 and PD-L1 Inhibitors Players by Sales (2015-2020)
3.2 Global Top PD-1 and PD-L1 Inhibitors Players by Revenue (2015-2020)
3.3 Global PD-1 and PD-L1 Inhibitors Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in PD-1 and PD-L1 Inhibitors as of 2019)
3.4 Global PD-1 and PD-L1 Inhibitors Average Price by Company (2015-2020)
3.5 Manufacturers PD-1 and PD-L1 Inhibitors Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key PD-1 and PD-L1 Inhibitors Players (Opinion Leaders)
4 Global PD-1 and PD-L1 Inhibitors Market Size by Type
4.1 Global PD-1 and PD-L1 Inhibitors Historic Market Review by Type (2015-2020)
4.1.1 Global PD-1 and PD-L1 Inhibitors Sales Market Share by Type (2015-2020)
4.1.2 Global PD-1 and PD-L1 Inhibitors Revenue Market Share by Type (2015-2020)
4.1.3 Global PD-1 and PD-L1 Inhibitors Price by Type (2015-2020)
4.2 Global PD-1 and PD-L1 Inhibitors Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global PD-1 and PD-L1 Inhibitors Sales Forecast by Type (2021-2026)
4.2.2 Global PD-1 and PD-L1 Inhibitors Revenue Forecast by Type (2021-2026)
4.2.3 Global PD-1 and PD-L1 Inhibitors Price Forecast by Type (2021-2026)
5 Global PD-1 and PD-L1 Inhibitors Market Size by Application
5.1 Global PD-1 and PD-L1 Inhibitors Historic Market Review by Application (2015-2020)
5.1.1 Global PD-1 and PD-L1 Inhibitors Sales Market Share by Application (2015-2020)
5.1.2 Global PD-1 and PD-L1 Inhibitors Revenue Market Share by Application (2015-2020)
5.1.3 Global PD-1 and PD-L1 Inhibitors Price by Application (2015-2020)
5.2 Global PD-1 and PD-L1 Inhibitors Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global PD-1 and PD-L1 Inhibitors Sales Forecast by Application (2021-2026)
5.2.2 Global PD-1 and PD-L1 Inhibitors Revenue Forecast by Application (2021-2026)
5.2.3 Global PD-1 and PD-L1 Inhibitors Price Forecast by Application (2021-2026)
6 United States PD-1 and PD-L1 Inhibitors Market Facts & Figures
6.1 United States PD-1 and PD-L1 Inhibitors Sales Market Share by Company (2015-2020)
6.2 United States PD-1 and PD-L1 Inhibitors Sales Market Share by Type (2015-2020)
6.3 United States PD-1 and PD-L1 Inhibitors Sales Market Share by Application (2015-2020)
7 Europe PD-1 and PD-L1 Inhibitors Market Facts & Figures
7.1 Europe PD-1 and PD-L1 Inhibitors Sales Market Share by Company (2015-2020)
7.2 Europe PD-1 and PD-L1 Inhibitors Sales Market Share by Type (2015-2020)
7.3 Europe PD-1 and PD-L1 Inhibitors Sales Market Share by Application (2015-2020)
8 China PD-1 and PD-L1 Inhibitors Market Facts & Figures
8.1 China PD-1 and PD-L1 Inhibitors Sales Market Share by Company (2015-2020)
8.2 China PD-1 and PD-L1 Inhibitors Sales Market Share by Type (2015-2020)
8.3 China PD-1 and PD-L1 Inhibitors Sales Market Share by Application (2015-2020)
9 Japan PD-1 and PD-L1 Inhibitors Market Facts & Figures
9.1 Japan PD-1 and PD-L1 Inhibitors Sales Market Share by Company (3015-3030)
9.2 Japan PD-1 and PD-L1 Inhibitors Sales Market Share by Type (2015-2020)
9.3 Japan PD-1 and PD-L1 Inhibitors Sales Market Share by Application (2015-2020)
10 Southeast Asia PD-1 and PD-L1 Inhibitors Market Facts & Figures
10.1 Southeast Asia PD-1 and PD-L1 Inhibitors Sales Market Share by Company (2015-2020)
10.2 Southeast Asia PD-1 and PD-L1 Inhibitors Sales Market Share by Type (2015-2020)
10.3 Southeast Asia PD-1 and PD-L1 Inhibitors Sales Market Share by Application (2015-2020)
11 India PD-1 and PD-L1 Inhibitors Market Facts & Figures
11.1 India PD-1 and PD-L1 Inhibitors Sales Market Share by Company (2015-2020)
11.2 India PD-1 and PD-L1 Inhibitors Sales Market Share by Type (2015-2020)
11.3 India PD-1 and PD-L1 Inhibitors Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in PD-1 and PD-L1 Inhibitors Business
12.1 Merck
12.1.1 Merck Corporation Information
12.1.2 Merck Business Overview
12.1.3 Merck PD-1 and PD-L1 Inhibitors Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Merck PD-1 and PD-L1 Inhibitors Products Offered
12.1.5 Merck Recent Development
12.2 Bristol-Myers Squibb
12.2.1 Bristol-Myers Squibb Corporation Information
12.2.2 Bristol-Myers Squibb Business Overview
12.2.3 Bristol-Myers Squibb PD-1 and PD-L1 Inhibitors Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Bristol-Myers Squibb PD-1 and PD-L1 Inhibitors Products Offered
12.2.5 Bristol-Myers Squibb Recent Development
12.3 Roche
12.3.1 Roche Corporation Information
12.3.2 Roche Business Overview
12.3.3 Roche PD-1 and PD-L1 Inhibitors Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Roche PD-1 and PD-L1 Inhibitors Products Offered
12.3.5 Roche Recent Development
12.4 AstraZeneca
12.4.1 AstraZeneca Corporation Information
12.4.2 AstraZeneca Business Overview
12.4.3 AstraZeneca PD-1 and PD-L1 Inhibitors Sales, Revenue and Gross Margin (2015-2020)
12.4.4 AstraZeneca PD-1 and PD-L1 Inhibitors Products Offered
12.4.5 AstraZeneca Recent Development
12.5 Ono Pharmaceutical
12.5.1 Ono Pharmaceutical Corporation Information
12.5.2 Ono Pharmaceutical Business Overview
12.5.3 Ono Pharmaceutical PD-1 and PD-L1 Inhibitors Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Ono Pharmaceutical PD-1 and PD-L1 Inhibitors Products Offered
12.5.5 Ono Pharmaceutical Recent Development
12.6 Regeneron
12.6.1 Regeneron Corporation Information
12.6.2 Regeneron Business Overview
12.6.3 Regeneron PD-1 and PD-L1 Inhibitors Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Regeneron PD-1 and PD-L1 Inhibitors Products Offered
12.6.5 Regeneron Recent Development
12.7 Innovent
12.7.1 Innovent Corporation Information
12.7.2 Innovent Business Overview
12.7.3 Innovent PD-1 and PD-L1 Inhibitors Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Innovent PD-1 and PD-L1 Inhibitors Products Offered
12.7.5 Innovent Recent Development
12.8 Hengrui Medicine
12.8.1 Hengrui Medicine Corporation Information
12.8.2 Hengrui Medicine Business Overview
12.8.3 Hengrui Medicine PD-1 and PD-L1 Inhibitors Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Hengrui Medicine PD-1 and PD-L1 Inhibitors Products Offered
12.8.5 Hengrui Medicine Recent Development
12.9 Junshi Biosciences
12.9.1 Junshi Biosciences Corporation Information
12.9.2 Junshi Biosciences Business Overview
12.9.3 Junshi Biosciences PD-1 and PD-L1 Inhibitors Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Junshi Biosciences PD-1 and PD-L1 Inhibitors Products Offered
12.9.5 Junshi Biosciences Recent Development
12.10 Merck KGaA
12.10.1 Merck KGaA Corporation Information
12.10.2 Merck KGaA Business Overview
12.10.3 Merck KGaA PD-1 and PD-L1 Inhibitors Sales, Revenue and Gross Margin (2015-2020)
12.10.4 Merck KGaA PD-1 and PD-L1 Inhibitors Products Offered
12.10.5 Merck KGaA Recent Development
13 PD-1 and PD-L1 Inhibitors Manufacturing Cost Analysis
13.1 PD-1 and PD-L1 Inhibitors Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of PD-1 and PD-L1 Inhibitors
13.4 PD-1 and PD-L1 Inhibitors Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 PD-1 and PD-L1 Inhibitors Distributors List
14.3 PD-1 and PD-L1 Inhibitors Customers
15 Market Dynamics
15.1 PD-1 and PD-L1 Inhibitors Market Trends
15.2 PD-1 and PD-L1 Inhibitors Opportunities and Drivers
15.3 PD-1 and PD-L1 Inhibitors Market Challenges
15.4 PD-1 and PD-L1 Inhibitors Market Restraints
15.5 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global PD-1 and PD-L1 Inhibitors Sales (L) Growth Rate by Type (2020-2026) (US$ Million)
Table 2. Global PD-1 and PD-L1 Inhibitors Sales (L) Comparison by Application (2020-2026) (US$ Million)
Table 3. Global Market PD-1 and PD-L1 Inhibitors Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 4. Global PD-1 and PD-L1 Inhibitors Sales (L) by Region (2015-2020)
Table 5. Global PD-1 and PD-L1 Inhibitors Sales Market Share by Region (2015-2020)
Table 6. Global PD-1 and PD-L1 Inhibitors Revenue (US$ Million) Market Share by Region (2015-2020))
Table 7. Global PD-1 and PD-L1 Inhibitors Revenue Share by Region (2015-2020)
Table 8. Global PD-1 and PD-L1 Inhibitors Sales (L) Forecast by Region (2021-2026)
Table 9. Global PD-1 and PD-L1 Inhibitors Sales Market Share Forecast by Region (2021-2026)
Table 10. Global PD-1 and PD-L1 Inhibitors Revenue (US$ Million) Forecast by Region (2021-2026)
Table 11. Global PD-1 and PD-L1 Inhibitors Revenue Share Forecast by Region (2021-2026)
Table 12. Global PD-1 and PD-L1 Inhibitors (L) of Key Companies (2015-2020)
Table 13. Global PD-1 and PD-L1 Inhibitors Sales Share by Company (2015-2020)
Table 14. Global PD-1 and PD-L1 Inhibitors Revenue (US$ Million) by Company (2015-2020)
Table 15. Global PD-1 and PD-L1 Inhibitors Revenue Share by Company (2015-2020)
Table 16. Global PD-1 and PD-L1 Inhibitors by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in PD-1 and PD-L1 Inhibitors as of 2019)
Table 17. Global PD-1 and PD-L1 Inhibitors Average Price (USD/ml) of Key Company (2015-2020)
Table 18. Manufacturers PD-1 and PD-L1 Inhibitors Manufacturing Sites and Area Served
Table 19. Manufacturers PD-1 and PD-L1 Inhibitors Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Main Points Interviewed from Key PD-1 and PD-L1 Inhibitors Players
Table 22. Global PD-1 and PD-L1 Inhibitors Sales (L) by Type (2015-2020)
Table 23. Global PD-1 and PD-L1 Inhibitors Sales Share by Type (2015-2020)
Table 24. Global PD-1 and PD-L1 Inhibitors Revenue (US$ Million) Market Share by Type (2015-2020)
Table 25. Global PD-1 and PD-L1 Inhibitors Price (L) by Type (2015-2020)
Table 26. Global PD-1 and PD-L1 Inhibitors Sales Share by Type (2021-2026)
Table 27. Global PD-1 and PD-L1 Inhibitors Revenue (US$ Million) Market Share by Type (2021-2026)
Table 28. Global PD-1 and PD-L1 Inhibitors Revenue Share by Type (2021-2026)
Table 29. Global PD-1 and PD-L1 Inhibitors Price (L) by Type (2021-2026)
Table 30. Global PD-1 and PD-L1 Inhibitors Sales (L) by Application (2015-2020)
Table 31. Global PD-1 and PD-L1 Inhibitors Sales Share by Application (2015-2020)
Table 32. Global PD-1 and PD-L1 Inhibitors Revenue (US$ Million) Market Share by Application (2015-2020)
Table 33. Global PD-1 and PD-L1 Inhibitors Price (L) by Application (2015-2020)
Table 34. Global PD-1 and PD-L1 Inhibitors Sales (L) by Application (2021-2026)
Table 35. Global PD-1 and PD-L1 Inhibitors Sales Share by Application (2021-2026)
Table 36. Global PD-1 and PD-L1 Inhibitors Revenue (US$ Million) Market Share by Application (2021-2026)
Table 37. Global PD-1 and PD-L1 Inhibitors Revenue Share by Application (2021-2026)
Table 38. Global PD-1 and PD-L1 Inhibitors Price (L) by Application (2021-2026)
Table 39. United States PD-1 and PD-L1 Inhibitors Sales (L) by Company (2015-2020)
Table 40. United States PD-1 and PD-L1 Inhibitors Sales Market Share by Company (2015-2020)
Table 41. United States PD-1 and PD-L1 Inhibitors Sales (L) by Type (2015-2020)
Table 42. United States PD-1 and PD-L1 Inhibitors Sales Market Share by Type (2015-2020)
Table 43. United States PD-1 and PD-L1 Inhibitors Sales (L) by Application (2015-2020)
Table 44. United States PD-1 and PD-L1 Inhibitors Sales Market Share by Application (2015-2020)
Table 45. Europe PD-1 and PD-L1 Inhibitors Sales (L) by Company (2015-2020)
Table 46. Europe PD-1 and PD-L1 Inhibitors Sales Market Share by Company (2015-2020)
Table 47. Europe PD-1 and PD-L1 Inhibitors Sales (L) by Type (2015-2020)
Table 48. Europe PD-1 and PD-L1 Inhibitors Sales Market Share by Type (2015-2020)
Table 49. Europe PD-1 and PD-L1 Inhibitors Sales (L) by Application (2015-2020)
Table 50. Europe PD-1 and PD-L1 Inhibitors Sales Market Share by Type (2015-2020)
Table 51. China PD-1 and PD-L1 Inhibitors Sales (L) by Company (2015-2020)
Table 52. China PD-1 and PD-L1 Inhibitors Sales Market Share by Company (2015-2020)
Table 53. China PD-1 and PD-L1 Inhibitors Sales (L) by Type (2015-2020)
Table 54. China PD-1 and PD-L1 Inhibitors Sales Market Share by Type (2015-2020)
Table 55. China PD-1 and PD-L1 Inhibitors Sales (L) by Application (2015-2020)
Table 56. China PD-1 and PD-L1 Inhibitors Sales Market Share by Application (2015-2020)
Table 57. Japan PD-1 and PD-L1 Inhibitors Sales (L) by Company (2015-2020)
Table 58. Japan PD-1 and PD-L1 Inhibitors Sales Market Share by Company (2015-2020)
Table 59. Japan PD-1 and PD-L1 Inhibitors Sales (L) by Type (2015-2020)
Table 60. Japan PD-1 and PD-L1 Inhibitors Sales Market Share by Type (2015-2020)
Table 61. Japan PD-1 and PD-L1 Inhibitors Sales (L) by Application (2015-2020)
Table 62. Japan PD-1 and PD-L1 Inhibitors Sales Market Share by Application (2015-2020)
Table 63. Southeast Asia PD-1 and PD-L1 Inhibitors Sales (L) by Company (2015-2020)
Table 64. Southeast Asia PD-1 and PD-L1 Inhibitors Sales Market Share by Company (2015-2020)
Table 65. Southeast Asia PD-1 and PD-L1 Inhibitors Sales (L) by Type (2015-2020)
Table 66. Southeast Asia PD-1 and PD-L1 Inhibitors Sales Market Share by Type (2015-2020)
Table 67. Southeast Asia PD-1 and PD-L1 Inhibitors Sales (L) by Type (2015-2020)
Table 68. Southeast Asia PD-1 and PD-L1 Inhibitors Sales Market Share by Application (2015-2020)
Table 69. India PD-1 and PD-L1 Inhibitors Sales (L) by Company (2015-2020)
Table 70. India PD-1 and PD-L1 Inhibitors Sales Market Share by Company (2015-2020)
Table 71. India PD-1 and PD-L1 Inhibitors Sales (L) by Type (2015-2020)
Table 72. India PD-1 and PD-L1 Inhibitors Sales Market Share by Type (2015-2020)
Table 73. India PD-1 and PD-L1 Inhibitors Sales (L) by Application (2015-2020)
Table 74. India PD-1 and PD-L1 Inhibitors Sales Market Share by Application (2015-2020)
Table 75. Merck Corporation Information
Table 76. Merck Description and Business Overview
Table 77. Merck PD-1 and PD-L1 Inhibitors Sales (L), Revenue (Million USD), Price (USD/ml) and Gross Margin (2015-2020)
Table 78. Merck PD-1 and PD-L1 Inhibitors Product
Table 79. Merck Recent Development
Table 80. Bristol-Myers Squibb Corporation Information
Table 81. Bristol-Myers Squibb Description and Business Overview
Table 82. Bristol-Myers Squibb PD-1 and PD-L1 Inhibitors Sales (L), Revenue (Million USD), Price (USD/ml) and Gross Margin (2015-2020)
Table 83. Bristol-Myers Squibb PD-1 and PD-L1 Inhibitors Product
Table 84. Bristol-Myers Squibb Recent Development
Table 85. Roche Corporation Information
Table 86. Roche Description and Business Overview
Table 87. Roche PD-1 and PD-L1 Inhibitors Sales (L), Revenue (Million USD), Price (USD/ml) and Gross Margin (2015-2020)
Table 88. Roche PD-1 and PD-L1 Inhibitors Product
Table 89. Roche Recent Development
Table 90. AstraZeneca Corporation Information
Table 91. AstraZeneca Description and Business Overview
Table 92. AstraZeneca PD-1 and PD-L1 Inhibitors Sales (L), Revenue (Million USD), Price (USD/ml) and Gross Margin (2015-2020)
Table 93. AstraZeneca PD-1 and PD-L1 Inhibitors Product
Table 94. AstraZeneca Recent Development
Table 95. Ono Pharmaceutical Corporation Information
Table 96. Ono Pharmaceutical Description and Business Overview
Table 97. Ono Pharmaceutical PD-1 and PD-L1 Inhibitors Sales (L), Revenue (Million USD), Price (USD/ml) and Gross Margin (2015-2020)
Table 98. Ono Pharmaceutical PD-1 and PD-L1 Inhibitors Product
Table 99. Ono Pharmaceutical Recent Development
Table 100. Regeneron Corporation Information
Table 101. Regeneron Description and Business Overview
Table 102. Regeneron PD-1 and PD-L1 Inhibitors Sales (L), Revenue (Million USD), Price (USD/ml) and Gross Margin (2015-2020)
Table 103. Regeneron PD-1 and PD-L1 Inhibitors Product
Table 104. Regeneron Recent Development
Table 105. Innovent Corporation Information
Table 106. Innovent Description and Business Overview
Table 107. Innovent PD-1 and PD-L1 Inhibitors Sales (L), Revenue (Million USD), Price (USD/ml) and Gross Margin (2015-2020)
Table 108. Innovent PD-1 and PD-L1 Inhibitors Product
Table 109. Innovent Recent Development
Table 110. Hengrui Medicine Corporation Information
Table 111. Hengrui Medicine PD-1 and PD-L1 Inhibitors Sales (L), Revenue (Million USD), Price (USD/ml) and Gross Margin (2015-2020)
Table 112. Hengrui Medicine Description and Business Overview
Table 113. Hengrui Medicine PD-1 and PD-L1 Inhibitors Product
Table 114. Hengrui Medicine Recent Development
Table 115. Junshi Biosciences Corporation Information
Table 116. Junshi Biosciences PD-1 and PD-L1 Inhibitors Sales (L), Revenue (Million USD), Price (USD/ml) and Gross Margin (2015-2020)
Table 117. Junshi Biosciences Description and Business Overview
Table 118. Junshi Biosciences PD-1 and PD-L1 Inhibitors Product
Table 119. Junshi Biosciences Recent Development
Table 120. Merck KGaA Corporation Information
Table 121. Merck KGaA Description and Business Overview
Table 122. Merck KGaA PD-1 and PD-L1 Inhibitors Sales (L), Revenue (Million USD), Price (USD/ml) and Gross Margin (2015-2020)
Table 123. Merck KGaA PD-1 and PD-L1 Inhibitors Product
Table 124. Merck KGaA Recent Development
Table 125. Production Base and Market Concentration Rate of Raw Material
Table 126. Key Suppliers of Raw Materials
Table 127. PD-1 and PD-L1 Inhibitors Distributors List
Table 128. PD-1 and PD-L1 Inhibitors Customers List
Table 129. PD-1 and PD-L1 Inhibitors Market Key Trends
Table 130. PD-1 and PD-L1 Inhibitors Key Opportunities and Drivers
Table 131. PD-1 and PD-L1 Inhibitors Market Challenges
Table 132. Research Programs/Design for This Report
Table 133. Key Data Information from Secondary Sources
Table 134. Key Data Information from Primary Sources
List of Figures
Figure 1. PD-1 and PD-L1 Inhibitors Product Picture
Figure 2. Global PD-1 and PD-L1 Inhibitors Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global PD-1 and PD-L1 Inhibitors Market Share by Application in 2020 & 2026
Figure 6. Solid Tumors Examples
Figure 7. Blood-related Tumors Examples
Figure 8. Global PD-1 and PD-L1 Inhibitors Sales (L) Growth Rate (2015-2026)
Figure 9. Global PD-1 and PD-L1 Inhibitors Revenue (US$ Million) Growth Rate (2015-2026)
Figure 10. Global PD-1 and PD-L1 Inhibitors Price Trends Growth Rate (2015-2026) (USD/ml)
Figure 11. Global PD-1 and PD-L1 Inhibitors Revenue Market Share by Region: 2015 VS 2020
Figure 12. Global PD-1 and PD-L1 Inhibitors Revenue Market Share by Region: 2021 VS 2026
Figure 13. United States PD-1 and PD-L1 Inhibitors Revenue (Million USD) Growth Rate (2015-2026)
Figure 14. United States PD-1 and PD-L1 Inhibitors Sales (L) Growth Rate (2015-2026)
Figure 15. Europe PD-1 and PD-L1 Inhibitors Revenue (Million USD) Growth Rate (2015-2026)
Figure 16. Europe PD-1 and PD-L1 Inhibitors Sales (Million USD) Growth Rate (2015-2026)
Figure 17. China PD-1 and PD-L1 Inhibitors Revenue (Million USD) Growth Rate (2015-2026)
Figure 18. China PD-1 and PD-L1 Inhibitors Sales (Million USD) and Growth Rate (2015-2026)
Figure 19. Japan PD-1 and PD-L1 Inhibitors Revenue (Million USD) Growth Rate (2015-2026)
Figure 20. Japan PD-1 and PD-L1 Inhibitors Sales (Million USD) Growth Rate (2015-2026)
Figure 21. Southeast Asia PD-1 and PD-L1 Inhibitors Revenue (Million USD) Growth Rate (2015-2026)
Figure 22. Southeast Asia PD-1 and PD-L1 Inhibitors Sales (Million USD) Growth Rate (2015-2026)
Figure 23. India PD-1 and PD-L1 Inhibitors Revenue (Million USD) Growth Rate (2015-2026)
Figure 24. India PD-1 and PD-L1 Inhibitors Sales (Million USD) Growth Rate (2015-2026)
Figure 25. Global 5 Largest PD-1 and PD-L1 Inhibitors Players Market Share by Revenue in PD-1 and PD-L1 Inhibitors 2015 & 2019
Figure 26. PD-1 and PD-L1 Inhibitors Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 27. Global PD-1 and PD-L1 Inhibitors Revenue Share by Type (2015-2020)
Figure 28. Global PD-1 and PD-L1 Inhibitors Revenue Growth Rate by Type in 2015 & 2019
Figure 29. Global PD-1 and PD-L1 Inhibitors Revenue Share by Application (2015-2020)
Figure 30. Global PD-1 and PD-L1 Inhibitors Revenue Growth Rate by Application in 2015 & 2019
Figure 31. United States PD-1 and PD-L1 Inhibitors Sales Market Share by Type in 2019
Figure 32. United States PD-1 and PD-L1 Inhibitors Sales Market Share by Type in 2019
Figure 33. Europe PD-1 and PD-L1 Inhibitors Sales Market Share by Company in 2019
Figure 34. Europe PD-1 and PD-L1 Inhibitors Sales Market Share by Type in 2019
Figure 35. Europe PD-1 and PD-L1 Inhibitors Sales Market Share by Application in 2019
Figure 36. China PD-1 and PD-L1 Inhibitors Sales Market Share by Company in 2019
Figure 37. China PD-1 and PD-L1 Inhibitors Sales Market Share by Type in 2019
Figure 38. China PD-1 and PD-L1 Inhibitors Sales Market Share by Application in 2019
Figure 39. Japan PD-1 and PD-L1 Inhibitors Sales Market Share by Company in 2019
Figure 40. Japan PD-1 and PD-L1 Inhibitors Sales Market Share by Type in 2019
Figure 41. Japan PD-1 and PD-L1 Inhibitors Sales Market Share by Application in 2019
Figure 42. Southeast Asia PD-1 and PD-L1 Inhibitors Sales Market Share by Company in 2019
Figure 43. Southeast Asia PD-1 and PD-L1 Inhibitors Sales Market Share by Type in 2019
Figure 44. Southeast Asia PD-1 and PD-L1 Inhibitors Sales Market Share by Application in 2019
Figure 45. India PD-1 and PD-L1 Inhibitors Sales Market Share by Company in 2019
Figure 46. India PD-1 and PD-L1 Inhibitors Sales Market Share by Type in 2019
Figure 47. India PD-1 and PD-L1 Inhibitors Sales Market Share by Application in 2019
Figure 48. Key Raw Materials Price Trend
Figure 49. Manufacturing Cost Structure of PD-1 and PD-L1 Inhibitors
Figure 50. Manufacturing Process Analysis of PD-1 and PD-L1 Inhibitors
Figure 51. PD-1 and PD-L1 Inhibitors Industrial Chain Analysis
Figure 52. Channels of Distribution
Figure 53. Distributors Profiles
Figure 54. Porter's Five Forces Analysis
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
Figure 57. Key Executives Interviewed
レニン阻害剤の世界市場レポート2020 Renin inhibitors are one of four classes of compounds that affect the renin-angiotensin-aldosterone system. Renin inhibitors produce vasodilation by inhibiting the activity of renin, which is responsible for stimulating angiotensin II formation. Renin is a proteolytic enzyme that is released by the …- プロトンポンプ阻害剤の世界市場レポート2020 Market Analysis and Insights: Global Proton Pump Inhibitors Market The global Proton Pump Inhibitors market size is projected to reach US$ 2750.5 million by 2026, from US$ 2404.3 million in 2020, at a CAGR of 2.3% during 2021-2026. Global Proton Pump Inhibitors Scope and Market Size The global Proto…
- 移行阻害剤の世界市場レポート2020 Market Analysis and Insights: Global Migration Inhibitors Market The global Migration Inhibitors market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026. Global Migration Inhibitors Scope and Market Size The global Migration Inhibitors…
- ヒストンデアセチラーゼ阻害剤の世界市場レポート2020 Market Analysis and Insights: Global Histone Deacetylase Inhibitors Market The global Histone Deacetylase Inhibitors market size is projected to reach US$ 2043.7 million by 2026, from US$ 1028 million in 2020, at a CAGR of 12.1% during 2021-2026. Global Histone Deacetylase Inhibitors Scope and Marke…
- チロシンキナーゼJAK阻害剤の世界市場レポート2020 Janus kinase inhibitors, also known as JAK inhibitors or jakinibs, are a type of medication that functions by inhibiting the activity of one or more of the Janus kinase family of enzymes (JAK1, JAK2, JAK3, TYK2), thereby interfering with the JAK-STAT signaling pathway. These inhibitors have therapeu…